Rigel Pharmaceuticals (RIGL) Gross Margin (2018 - 2026)
Rigel Pharmaceuticals' quarterly Gross Margin came in at 92.17% in Q1 2026, up 44.0% year-on-year from 64.01% in Q1 2025, and up 0.77% quarter-over-quarter from 91.47% in Q4 2025.
Rigel Pharmaceuticals has reported Gross Margin for 9 years, with the latest figure at 92.17% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 44.0% year-over-year to 92.17%; the trailing twelve-month figure through Mar 2026 stood at 93.39% (up 375.0% YoY), and the FY2025 full-year result was 93.33%, up 373.0% from the prior year.
- Gross Margin for Q1 2026 stood at 92.17%, up from 91.47% in the prior quarter.
- The five-year high for Gross Margin was 99.33% in Q4 2022, with the low at 85.49% in Q3 2024.
- Average Gross Margin over 5 years is 93.9%, with a median of 93.16% recorded in 2025.
- Year-over-year, Gross Margin tumbled 1000 bps in 2024 and jumped 767 bps in 2025.
- Tracing RIGL's Gross Margin over 5 years: stood at 99.33% in 2022, then slipped by 10 bps to 89.41% in 2023, then grew by 1 bps to 89.95% in 2024, then advanced by 2 bps to 91.47% in 2025, then advanced by 1 bps to 92.17% in 2026.
- The last three Gross Margin figures came in at 92.17% (Q1 2026), 91.47% (Q4 2025), and 93.16% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 92.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.17% |
| Dec 31, 2025 | 91.47% |
| Sep 30, 2025 | 93.16% |
| Jun 30, 2025 | 95.57% |
| Mar 31, 2025 | 91.73% |
| Dec 31, 2024 | 89.95% |
| Sep 30, 2024 | 85.49% |
| Jun 30, 2024 | 92.38% |
| Mar 31, 2024 | 93.14% |
| Dec 31, 2023 | 89.41% |
| Sep 30, 2023 | 95.49% |
| Jun 30, 2023 | 96.00% |
| Mar 31, 2023 | 96.25% |
| Dec 31, 2022 | 99.33% |
| Sep 30, 2022 | 98.88% |
| Jun 30, 2022 | 96.53% |
| Mar 31, 2022 | 99.28% |
| Dec 31, 2021 | 97.61% |
| Sep 30, 2021 | 99.30% |
| Jun 30, 2021 | 99.51% |
| Mar 31, 2021 | 99.61% |
| Dec 31, 2020 | 98.26% |
| Sep 30, 2020 | 99.24% |
| Jun 30, 2020 | 98.26% |
| Mar 31, 2020 | 99.72% |
| Dec 31, 2019 | 98.84% |
| Sep 30, 2019 | 98.51% |
| Jun 30, 2019 | 97.01% |
| Mar 31, 2019 | 99.15% |
| Dec 31, 2018 | 99.50% |
| Sep 30, 2018 | 98.58% |
| Jun 30, 2018 | 98.32% |